221 related articles for article (PubMed ID: 9952238)
1. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection.
Sawayama Y; Hayashi J; Kawakami Y; Furusyo N; Ariyama I; Kishihara Y; Ueno K; Kashiwagi S
Dig Dis Sci; 1999 Jan; 44(1):163-9. PubMed ID: 9952238
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble interleukin-2 receptor levels in patients with chronic hepatitis B virus infection and its relation with anti-HBc.
Xiao P; Chen QF; Yang YL; Guo ZH; Chen H
World J Gastroenterol; 2006 Jan; 12(3):482-4. PubMed ID: 16489655
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.
Hayashi J; Kishihara Y; Yamaji K; Yoshimura E; Ohmiya M; Tani Y; Ikematsu H; Kashiwagi S
Dig Dis Sci; 1995 Aug; 40(8):1837-41. PubMed ID: 7648988
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group.
Naveau S; Balian A; Degos F; Daurat V; Chevret S; Gayno S; Bastie A; Riachi G; Bartolomei-Portal I; Barange K; Moussalli J; Bailly F; Chaumet-Riffaud P; Emilie D
J Hepatol; 1999 Oct; 31(4):612-7. PubMed ID: 10551383
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis.
Alberti A; Chemello L; Fattovich G; Pontisso P; Semenzato G; Colletta C; Vinante F; Pizzolo G
Dig Dis Sci; 1989 Oct; 34(10):1559-63. PubMed ID: 2507263
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein.
Izzo F; Cremona F; Delrio P; Leonardi E; Castello G; Pignata S; Daniele B; Curley SA
Ann Surg Oncol; 1999 Mar; 6(2):178-85. PubMed ID: 10082044
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
8. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha.
Morishima I; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Ohki H; Suga T; Ito O
Scand J Gastroenterol; 1995 Aug; 30(8):807-11. PubMed ID: 7481551
[TBL] [Abstract][Full Text] [Related]
10. Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases.
Yamaguchi S; Onji M; Ohta Y
Hepatogastroenterology; 1988 Oct; 35(5):245-8. PubMed ID: 3068111
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
[TBL] [Abstract][Full Text] [Related]
12. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
Simsek H; Kadayifci A
J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
[TBL] [Abstract][Full Text] [Related]
13. Clinical observation of serum IL-18, IL-10 and sIL-2R levels in patients with chronic hepatitis C pre- and post antiviral treatment.
Jia H; Du J; Zhu S; Ma Y; Cai H
Chin Med J (Engl); 2003 Apr; 116(4):605-8. PubMed ID: 12875732
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-interferon and prednisone on serum-soluble interleukin-2 receptor (sIL-2R) in chronic hepatitis B infection.
Leung NW; Leung JC; Tam JS; Lau JT; Lai KN
Am J Gastroenterol; 1992 Jan; 87(1):113-7. PubMed ID: 1728107
[TBL] [Abstract][Full Text] [Related]
15. [Serum IL-2 and sIL-2R concentration in children with chronic hepatitis B].
Pawłowska M; Halota W; Smukalska E; Grabczewska E
Pol Merkur Lekarski; 2005 Jan; 18(103):33-5. PubMed ID: 15859543
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
[TBL] [Abstract][Full Text] [Related]
18. Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.
Abe S; Narita R; Matsuhashi T; Oto T; Tabaru A; Otsuki M
Eur J Gastroenterol Hepatol; 2008 May; 20(5):373-8. PubMed ID: 18403937
[TBL] [Abstract][Full Text] [Related]
19. T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics.
Tang JT; Fang JY; Gu WQ; Li EL
World J Gastroenterol; 2006 May; 12(19):3015-9. PubMed ID: 16718780
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
Grüngreiff K; Reinhold D; Ansorge S
Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
